Mohan Suntha

Mohan Suntha, MD, MBA, serves as Professor of Radiation Oncology at the University of Maryland School of Medicine and holds a secondary appointment in Otorhinolaryngology-Head & Neck Surgery. He concurrently serves as President and Chief Executive Officer of the University of Maryland Medical System (UMMS), a role he assumed in 2019 after previously leading the University of Maryland Medical Center since 2016.

His educational background includes:

• BA in Biology from Brown University (1986)
• MD from Jefferson Medical College (1990)
• Residency in Radiation Oncology at University of Maryland School of Medicine (1994)
• Clinical Oncology Fellowship in Head & Neck Malignancies (1994-1995)
• MBA from The Wharton School (2009)

Dr. Suntha's research focuses on carcinomas of the head, neck, and esophagus, with emphasis on optimizing combined modality approaches through investigator-initiated clinical trials. His work investigates concurrent chemoradiation protocols, neoadjuvant strategies, and surgical integration to improve therapeutic outcomes. Current investigations include tumor volume prognostic factors, molecular imaging applications, and quality indicators for surgical oncology procedures.

His publications demonstrate consistent focus on head and neck cancer disparities, esophageal carcinoma management, and quality metrics in radiation oncology. Key trends include translational research connecting surgical pathology metrics with oncologic outcomes, prognostic biomarker identification, and health equity analysis in cancer care delivery.

Award highlights include:

• Five-time 'Top Doctor' in Radiation Oncology by Baltimore Magazine (2007-2016)
• 2022 Influential Marylander Honoree in Healthcare by Maryland Daily Record

Administratively, Dr. Suntha has held progressive leadership roles including Vice Chair of Radiation Oncology, Associate Director of Clinical Affairs at UMGCCC, Vice President for System Program Development at UMMS, and CEO of St. Joseph Medical Center. His current UMMS presidency encompasses oversight of Shock Trauma Center, Children's Hospital, and Greenebaum Comprehensive Cancer Center. While maintaining active clinical faculty status, his executive responsibilities focus on system-wide strategic development and healthcare delivery innovation.